120
Participants
Start Date
April 30, 1999
Study Completion Date
May 31, 2001
RSV Polyclonal Immunoglobulin
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda
National Institute of Allergy and Infectious Diseases (NIAID)
NIH